Asensus Surgical Inc.

0.4173-0.0157-3.63%Vol 27.51M1Y Perf -86.59%
Jun 24th, 2022 16:00 DELAYED
BID0.4055 ASK0.4310
Open0.4455 Previous Close0.4330
Pre-Market- After-Market0.43
 - -  0.01 1.85%
Target Price
4.00 
Analyst Rating
Strong Buy 1.00
Potential %
858.54 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     57.94
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.82
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
2.07 
Earnings Rating
Market Cap98.68M 
Earnings Date
4th Aug 2022
Alpha0.02 Standard Deviation0.58
Beta1.68 

Today's Price Range

0.40000.4590

52W Range

0.35003.60

5 Year PE Ratio Range

-1.30-0.3000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
12.78%
1 Month
10.81%
3 Months
-30.80%
6 Months
-63.39%
1 Year
-86.59%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ASXC0.4173-0.0157-3.63
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
12.20
13.70
0.03
0.04
-112.50
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-35.90
-877.90
-684.10
-1 349.00
-
RevenueValueIndustryS&P 500US Markets
7.22M
0.03
-24.29
-0.29
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.08-0.0712.50
Q04 2021-0.07-0.070.00
Q03 2021-0.06-0.060.00
Q02 2021-0.06-0.0516.67
Q01 2021-0.07-0.0614.29
Q04 2020--0.09-
Q03 2020-0.23-0.1247.83
Q02 2020-0.38-0.2144.74
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume27.51M
Shares Outstanding236.46K
Shares Float234.19M
Trades Count14.28K
Dollar Volume11.54M
Avg. Volume3.21M
Avg. Weekly Volume4.37M
Avg. Monthly Volume2.67M
Avg. Quarterly Volume2.58M

Asensus Surgical Inc. (AMEX: ASXC) stock closed at 0.4173 per share at the end of the most recent trading day (a -3.63% change compared to the prior day closing price) with a volume of 27.51M shares and market capitalization of 98.68M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 138 people. Asensus Surgical Inc. CEO is Anthony C. J. Fernando.

The one-year performance of Asensus Surgical Inc. stock is -86.59%, while year-to-date (YTD) performance is -62.41%. ASXC stock has a five-year performance of %. Its 52-week range is between 0.35 and 3.5983, which gives ASXC stock a 52-week price range ratio of 2.07%

Asensus Surgical Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 0.58, a price-to-sale (PS) ratio of 12.13, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -32.93%, a ROC of -34.93% and a ROE of -36.02%. The company’s profit margin is -%, its EBITDA margin is -684.10%, and its revenue ttm is $7.22 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from Asensus Surgical Inc., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Asensus Surgical Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Asensus Surgical Inc. is Strong Buy (1), with a target price of $4, which is +858.54% compared to the current price. The earnings rating for Asensus Surgical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Asensus Surgical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Asensus Surgical Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 32.40, ATR14 : 0.04, CCI20 : 50.39, Chaikin Money Flow : -0.12, MACD : -0.01, Money Flow Index : 39.56, ROC : -5.16, RSI : 50.08, STOCH (14,3) : 44.05, STOCH RSI : 0.69, UO : 54.55, Williams %R : -55.95), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Asensus Surgical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Asensus Surgical Inc.

Asensus Surgical Inc is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

CEO: Anthony C. J. Fernando

Telephone: +1 919 765-8400

Address: 1 TW Alexander Drive, Durham 27703, NC, US

Number of employees: 138

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

63%38%

Bearish Bullish

68%32%

News

Stocktwits